Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Jundishapur Journal of Natural Pharmaceutical Products
  4. Articles

  5. The Effect of Nigella sativa Powder on Blood Sugar and Lipid Profiles in Type 2 Diabetic Patients
  6. Scopus by Title (Ref)

Jundishapur Journal of Natural Pharmaceutical Products

The Official Journal of Ahvaz Jundishapur University of Medical Sciences

Home
Current IssueAccepted ManuscriptsAll IssuesIn PressSearch
Instructions
Journal InformationBoard & CommitteeIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormJoin JJNPP EditorialSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Does Nigella sativa supplementation improve cardiovascular disease risk factors? A comprehensive GRADE-assessed systematic review and dose-response meta-analysis of 82 randomized controlled trials

- Jafari A. , et al.

2. NIGELLA SATIVA L.: AN OVERVIEW

- Gürel Ş.H. , et al.

3. Application of Nigella sativa as a functional food in diabetes and related complications: Insights on molecular, cellular, and metabolic effects

- Mashayekhi-Sardoo H. , et al.

4. Pro-Health Potential of Selected Uncommon Oilseed Plants

- Dereń K. , et al.

HomeInstructionsAPC

Archives

  • Current Issue
  • Accepted Manuscripts
  • All Issues
  • In Press
  • Search

About Journal

  • Journal Information
  • Board & Committee
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Join JJNPP Editorial
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.